Navigation Links
Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007
Date:2/29/2008

Total liabilities 1,530,554 1,834,313

SHAREHOLDERS' EQUITY 1,354,420 1,328,232

TOTAL LIABILITIES & SHAREHOLDERS'

EQUITY $2,884,974 $3,162,545

WARNER CHILCOTT LIMITED

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

(in thousands of U.S. dollars)

(Unaudited)

Quarter Ended Year Ended

Dec-31-07 Dec-31-06 Dec-31-07 Dec-31-06

CASH FLOWS FROM OPERATING

ACTIVITIES:

Net income / (loss) $19,687 $(8,520) $28,875 $(153,510)

Adjustments to reconcile net

income / (loss) to net cash

provided by operating

activities:

Depreciation 2,892 2,171 10,250 7,177

Amortization of intangible

assets 56,169 68,300 228,330 253,425

Amortization of debt finance

costs 3,280 11,135 13,813 30,154

Stock compensation expense 1,085 1,711 6,115 17,787

Accretion of preferred stock

in subsidiary - - - 26,190

Changes in assets and

liabilities:

Decrease / (increase) in

accounts receivable, prepaid

and other assets 12,742 12,780 1,852 (22,914)

(Increase) / decrease in

inventories (621) (6,955) 12,345 (34,978)

Increase in accounts payable,

accrued expenses & other

liabilities 17,107 1,888 32,430 7,933

(Decrease) / increase in

income taxes and other, net (6,507) (11,581) 5,540 (
'/>"/>

SOURCE Warner Chilcott Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results
2. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
3. Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2007 Financial Results
4. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
5. Warner Chilcott Announces Receipt of Paragraph IV Certification Notice
6. Cepheid Reports Fourth Quarter and Full Year 2007 Results
7. Strategic Diagnostics Reports Fourth Quarter and Full-Year Financial Results
8. US Oncology Reports Fourth Quarter and Fiscal Year 2007 Results
9. Barr Reports GAAP Earnings of $1.18 Per Share for 2007 and $0.30 Per Share for the Fourth Quarter; Adjusted Earnings Were $3.16 Per Share for 2007 and $0.79 Per Share for the Fourth Quarter
10. Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results
11. eResearchTechnology Reports Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014 Sales Horizons, a ... of blended sales training programs for companies engaged in ... programs used by thousands of salespeople over 25 years ... training program can be customized to address the unique ... blended sales training program consists of two ...
(Date:7/30/2014)... 2014 With the accelerated aging ... health expenditure as well as the improved medical ... diagnostic reagent industry has been developing quickly, especially ... 2013, Chinese in vitro diagnostics market size reached ... in vitro diagnostic reagents. , Read complete ...
(Date:7/30/2014)... Wellesley, MA (PRWEB) July 30, 2014 ... report, Global Markets for Enzymes in Industrial Applications ... to reach to nearly $7.1 billion by 2018, registering ... Maximum growth is estimated to be recorded in the ... the forecast period. , Enzyme technology has influenced almost ...
(Date:7/30/2014)... Yuma Regional Cancer Center Officially Opens ... comprehensive cancer care to Yuma, Arizona. , The ... has officially opened. A Mayo Clinic Care Network ... as open, semi-private and private infusion rooms, oncology ... Center, hematology, rehabilitation center, a pain management program ...
Breaking Biology Technology:Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 2Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 3China Diagnostic Reagent Industry Report, 2013-2016 | Researchmoz 2China Diagnostic Reagent Industry Report, 2013-2016 | Researchmoz 3Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 2Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 3Sate-of-the-Art Yuma Regional Cancer Center Officially Opens 2
... Md., Feb. 8, 2011 Spherix Incorporated (Nasdaq: ... in diabetes, metabolic syndrome and atherosclerosis; and providers of ... and pharmaceutical companies, today announced that its President, Dr. ... BIO CEO & Investor Conference to be held in ...
... Md., Feb. 8, 2011 United Therapeutics Corporation (Nasdaq: ... release its fourth quarter and annual 2010 financial results ... United Therapeutics will host a half-hour teleconference on ...  The teleconference is accessible by dialing 1-877-351-5881, with international ...
... 2011 -- A low cost, nanometer-sized drug to treat ... been developed by a group of scientists from the Hebrew ... U.S. and Japan. Diabetes is a rapidly growing ... population. Poor blood circulation arising from diabetes often results in ...
Cached Biology Technology:Spherix to Present at the 13th Annual BIO CEO & Investor Conference 2Spherix to Present at the 13th Annual BIO CEO & Investor Conference 3
(Date:7/30/2014)... from the University of Helsinki and the Universitat Autnoma ... mice morphological changes which have taken millions of years ... embryonic development of mice teeth, induced in the laboratory, ... to those observed in the fossil registry of rodent ... , To modify the development of their teeth, ...
(Date:7/30/2014)... dominance in female baboons suggests that the route to a ... to have lots of supportive sisters. , A female baboon,s ... by the rank of her mother - the higher the ... this reason, dominance rank in female baboons is thought to ... guaranteed a good spot in the pecking order, whereas females ...
(Date:7/30/2014)... HIV infection could be as simple as inserting a ... University of Washington bioengineers have discovered a potentially faster ... from contracting HIV. Their method spins the drug into ... moisture, releasing higher doses of the drug than possible ... , "This could offer women a potentially more effective, ...
Breaking Biology News(10 mins):Scientists reproduce evolutionary changes by manipulating embryonic development of mice 2Supportive moms and sisters boost female baboon's rank 2Supportive moms and sisters boost female baboon's rank 3Dissolvable fabric loaded with medicine might offer faster protection against HIV 2Dissolvable fabric loaded with medicine might offer faster protection against HIV 3
... wisdom teeth are not much more than an annoyance that ... in the September 17 Journal of Biological Chemistry ... for the creation of stem cells; thus, everyone might be ... he or she ever need some. Groundbreaking research back ...
... Mount Sinai School of Medicine have found that bisphenol A ... is detectable in the saliva after placement in children,s mouths. ... associated with changes in behavior, prostate and urinary tract development, ... the current issue of Pediatrics . Reins containing ...
... of Scots Pine trees, scientists have shown that the iconic ... the ancestors that colonised Britain after the end of the ... future populations, according to new results published in the journal ... an international team from the Centre for Ecology & Hydrology, ...
Cached Biology News:A smart use for wisdom teeth: Making stem cells 2Mount Sinai researchers analyze impact of chemical BPA in dental sealants used in children 2Scots Pine shows its continental roots 2
... is essential for hunting and analyzing ... such as EST sequencing projects, microarrays, ... kit is developed for normalization of ... intended for directional cloning. While most ...
Polyclonal Antibody to HADHB...
A431 cells Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
PC12 (rat phaeochromocytoma) cells Source: Cell Lysate Form: Ready to Use Application: Western Blotting Control...
Biology Products: